Cargando…
Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is a progressive multisystemic disease that increases significantly cardiovascular morbidity and mortality. It is associated with obesity, insulin resistance, beta-cell dysfunction, and hyperglucagonemia, the combination of which typically leads to hyperglycemia. Incr...
Autores principales: | Koliaki, Chrysi, Doupis, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare Communications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144767/ https://www.ncbi.nlm.nih.gov/pubmed/22127804 http://dx.doi.org/10.1007/s13300-011-0002-3 |
Ejemplares similares
-
Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: Fact or Fiction?
por: Tsilingiris, Dimitrios, et al.
Publicado: (2019) -
Novel Dual Incretin Receptor Agonists in the Spectrum of Metabolic Diseases with a Focus on Tirzepatide: Real Game-Changers or Great Expectations? A Narrative Review
por: Liarakos, Alexandros Leonidas, et al.
Publicado: (2023) -
Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist’s Perspective: Lessons Learned from Cardiovascular Outcome Trials
por: Koliaki, Chrysi, et al.
Publicado: (2019) -
Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence
por: Koliaki, Chrysi, et al.
Publicado: (2022) -
Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus
por: Yaribeygi, Habib, et al.
Publicado: (2021)